Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Acquisition

4 May 2022 07:00

RNS Number : 1863K
Restore PLC
04 May 2022
 

4 May 2022

 

Restore plc

("Restore" or the "Group" or "Company")

 

Strategic acquisition increases Restore Technology capability

 

 

Restore (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, is pleased to announce that it acquired 100% of the share capital of Ultratec (Holdings) Limited ("Ultratec") on 3rd May 2022.

 

This investment represents a further milestone in the Group's strategic development of Restore Technology.

 

Ultratec is a highly regarded provider of secure data erasure and physical data destruction services, bespoke technology recycling solutions, hard drive parts supply and Data Centre focussed hardware maintenance services.

 

A key feature of the business are the innovative and proprietary software solutions, Genesis* and Nemesis*. Both these products deliver additional value by extending the life of hard drive technologies, improving re-use recovery rates and securely erasing data substantially faster than comparable software solutions. The business has around 70 staff based in two locations at Stevenage and Henlow.

 

For the year to 31st March 2022, Ultratec achieved a revenue of £7.6 million, generating a profit before tax of £1.2 million and had net assets of £1.8 million. The business is being acquired in cash for an enterprise value of £9.4 million. In addition to the additional technical capability provided by the Genesis and Nemesis technologies, the combination will further increase the scale of Restore Technology and achieve synergies across revenues and operations.

 

*Genesis was developed by Ultratec as a proprietary software and hardware appliance that securely erases data on various hard disk formats and will also reconstruct hard drives to make previously damaged hard drives useable again. The appliance includes cloud based software to ease deployment and is delivered with a subscription model with recuring revenues. Nemesis performs the same functionality as Genesis but with networking equipment which is a growing market with the increasing amounts of data on networking devices posing a security risk for organisations.

 

www.ultratec.co.uk/genesis

www.ultratestsolutions.com

 

CHARLES BLIGH, CEO, COMMENTED:

 

"I am delighted to welcome the team at Ultratec to the Group and we look forward to developing the business together as part of Restore Technology, our rapidly growing IT lifecycle services business.

 

The team at Ultratec have an excellent reputation in the sector with a specialist focus on hard drive and storage products from repair, erasure and resale. Their innovative Genesis and Nemesis technologies represent opportunities to further expand our capabilities in technology lifecycle services. I am excited about this acquisition and the opportunity it represents for our business."

 

 

For further information:

Restore plc

www.restoreplc.com

Charles Bligh, CEONeil Ritchie, CFO

+44 (0) 207 409 2420

Investec (Nominated Adviser and Joint Broker)

www.investec.com

Carlton Nelson

James Rudd

 

+44 (0) 207 597 5970

Canaccord Genuity (Joint Broker, Corporate Advisor))

www.canaccordgenuity.com

Max Hartley

Chris Robinson

 

+44 (0) 207 523 8000

Citi (Joint Broker)

www.citigroup.com

Stuart Field

Luke Spells

 

+44 (0) 207 986 4074

Buchanan Communications (PR enquiries)

www.buchanan.uk.com

Charles Ryland

Stephanie Whitmore

 

+44 (0) 207 466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSSAFMDEESEDI
Date   Source Headline
4th Mar 20258:04 amRNSHolding(s) in Company
4th Feb 20259:23 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of full year results
21st Nov 20247:00 amRNSTrading Update
7th Nov 20247:00 amRNSNotice of Trading Update
31st Oct 20241:07 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSAnalyst and Investor Site Visit
22nd Oct 20242:26 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSBoard Change
2nd Sep 20247:00 amRNSDirector/PDMR Shareholding
23rd Aug 20249:21 amRNSDirector/PDMR Shareholding
16th Aug 202410:27 amRNSHolding(s) in Company
31st Jul 20247:00 amRNSHalf year results 2024
7th Jun 20247:49 amRNSHolding(s) in Company
3rd Jun 20241:17 pmRNSHolding(s) in Company
20th May 20242:03 pmRNSGrant of SAYE Options and PDMR Dealings
16th May 20244:29 pmRNSResult of Annual General Meeting
16th May 20247:00 amRNSTrading Update
12th Apr 20243:48 pmRNSHolding(s) in Company
5th Apr 20243:39 pmRNSDirector/PDMR Shareholding
25th Mar 20248:59 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSFull year 2023 results
18th Jan 20247:00 amRNSTrading Update and Notice of Full Year Results
20th Dec 20237:00 amRNSHolding(s) in Company
18th Dec 202311:38 amRNSDirector/PDMR Shareholding
20th Nov 20234:07 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update, Contract Award and CME
30th Oct 20237:00 amRNSBoard Changes
24th Oct 20233:33 pmRNSHolding(s) in Company
11th Oct 202312:07 pmRNSDirector/PDMR Shareholding
6th Oct 20233:52 pmRNSDirector/PDMR Shareholding
25th Sep 202310:55 amRNSDirector/PDMR Shareholding
22nd Sep 20234:43 pmRNSNotification of Major Holdings
12th Sep 20237:00 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSBoard Changes
16th Aug 20237:00 amRNSInterim CFO Appointment
16th Aug 20237:00 amRNSHalf Year Results 2023
1st Aug 20233:23 pmRNSNotification of Major Holdings
19th Jul 20232:35 pmRNSNotification of Major Holdings
4th Jul 20237:01 amRNSBoard Changes
4th Jul 20237:00 amRNSTrading Update
22nd Jun 20236:08 pmRNSDirector/PDMR, Grant of LTIP
14th Jun 20237:00 amRNSBoard Change
24th May 20234:37 pmRNSNOTIFICATION OF MAJOR HOLDINGS
18th May 20233:42 pmRNSNotification of Major Holdings
16th May 20234:18 pmRNSResult of Annual General Meeting
15th May 20237:00 amRNSTrading Update
11th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.